George Yancopoulos
Analyst
Equibles does not estimate personal net worth.
About George Yancopoulos
George Yancopoulos has spoken on 1 earnings call across 1 company, most recently for Regeneron Pharmaceuticals, Inc. on July 30, 2026. The companies whose calls George Yancopoulos spoke on are classified in the Healthcare sector.
George Yancopoulos on recent calls
“Today, I'll focus on the key updates from our development pipeline. For a comprehensive summary of our mid- and late-stage pipelines, please refer to the Programs and Clinical Development section of our 10-Q. I'll start with our complement-mediated disease franchise, beginning with Cymdicerine, our C5-SIRNA.”